Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dendritic cell vaccination.

Owen Proudfoot1, Dodie Pouniotis, Kuo-Ching Sheng

  • 1Bio-Organic and Medicinal Chemistry Laboratory, Burnet Institute at Austin, Studley Rd, Heidelberg, 3084, Victoria, Australia. oproudfoot@burnet.edu.au

Expert Review of Vaccines
|August 3, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Examining the benefits of industry clinical placements for medical laboratory science academics.

Laboratory medicine·2026
Same author

Platelet-targeted thromboprophylaxis with a human serum albumin fusion drug: Preventing thrombosis and reducing cardiac ischemia/reperfusion injurywithout bleeding complications.

Theranostics·2024
Same author

Self-Assembled Peptide Habitats to Model Tumor Metastasis.

Gels (Basel, Switzerland)·2022
Same author

Two-Dimensional and Three-Dimensional Time-of-Flight Secondary Ion Mass Spectrometry Image Feature Extraction Using a Spatially Aware Convolutional Autoencoder.

Analytical chemistry·2022
Same author

Fc Binding by FcγRIIa Is Essential for Cellular Activation by the Anti-FcγRIIa mAbs 8.26 and 8.2.

Frontiers in immunology·2021
Same author

Once daily 300 mg aspirin with compression versus compression alone in patients with chronic venous leg ulcers (ASPiVLU): A randomised, double-blinded, multicentre, placebo-controlled, clinical trial.

Journal of tissue viability·2021
Same journal

Projected health and economic impact of PCV20 vaccination in UK children: a dynamic transmission model.

Expert review of vaccines·2026
Same journal

Evaluating the societal value of adult respiratory vaccination in Sweden: a benefit-cost analysis.

Expert review of vaccines·2026
Same journal

Evaluating the socioeconomic value of adult respiratory immunization in Spain: a benefit-cost analysis.

Expert review of vaccines·2026
Same journal

Whole cell and acellular pertussis vaccines - rethinking the evidence.

Expert review of vaccines·2026
Same journal

Modeling the potential public health and economic impact and cost-effectiveness of vaccination strategies using an adapted COVID-19 vaccine in the Dominican Republic.

Expert review of vaccines·2026
Same journal

Narrative shielding and prebunking: a synergistic strategy against vaccine hesitancy in pediatrics.

Expert review of vaccines·2026
See all related articles

Dendritic cell (DC) vaccination shows promise for cancer immunotherapy but requires further research. This review covers preclinical models, DC subsets, and clinical trials for improved cancer treatment strategies.

Area of Science:

  • Immunology
  • Oncology
  • Cellular Therapy

Background:

  • Dendritic cell (DC) vaccination is a growing area of interest for cancer immunotherapy.
  • Despite promising results, DC vaccination is not yet a standard cancer therapy.

Purpose of the Study:

  • To review preclinical DC vaccination in murine cancer models.
  • To compare antigen priming methods in DC vaccination.
  • To discuss murine and human DC subsets and their clinical relevance.

Main Methods:

  • Review of preclinical studies in murine cancer models.
  • Analysis of comparative studies on antigen priming techniques.
  • Examination of DC subset characterization in mice and humans.
  • Overview of human DC generation methods and clinical trial data.

Related Experiment Videos

Main Results:

  • Preclinical studies provide insights into DC vaccination efficacy.
  • Different antigen priming methods show variable results in preclinical models.
  • Understanding DC subsets is crucial for translating preclinical findings to humans.
  • Clinical trials are exploring DC vaccination across various cancers.

Conclusions:

  • Further research is needed to optimize dendritic cell vaccination for cancer treatment.
  • Comparative studies and understanding DC subsets are key to advancing this therapy.
  • Clinical translation requires careful consideration of human DC preparations and trial outcomes.